Ellen Warner

18.4k total citations · 3 hit papers
198 papers, 8.3k citations indexed

About

Ellen Warner is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Ellen Warner has authored 198 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Oncology, 64 papers in Genetics and 56 papers in Cancer Research. Recurrent topics in Ellen Warner's work include BRCA gene mutations in cancer (64 papers), Breast Cancer Treatment Studies (45 papers) and Global Cancer Incidence and Screening (30 papers). Ellen Warner is often cited by papers focused on BRCA gene mutations in cancer (64 papers), Breast Cancer Treatment Studies (45 papers) and Global Cancer Incidence and Screening (30 papers). Ellen Warner collaborates with scholars based in Canada, United States and United Kingdom. Ellen Warner's co-authors include Andrea Eisen, Steven A. Narod, Petrina A. Causer, Donald B. Plewes, Rene Shumak, Corinne R. Leach, Samuel J. LaMonte, Mandi L. Pratt‐Chapman, Linda A. Jacobs and Rachel Cannady and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Ellen Warner

189 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Surveillance of <EMPH TYPE="ITAL">BRCA1</EMPH> and <EMPH TYPE="ITAL">BRCA2</EMPH> Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination

2004 857 citations Ellen Warner profile →
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

2015 734 citations Ellen Warner et al. Journal of Clinical Oncology profile →
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

2015 509 citations Ellen Warner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ellen Warner Canada	40	3.6k	2.7k	2.2k	1.6k	1.5k	198	8.3k
Andrea Eisen Canada	49	3.1k 0.8×	4.9k 1.8×	2.9k 1.3×	1.5k 0.9×	681 0.4×	189	8.3k
Elizabeth B. Claus United States	41	2.2k 0.6×	2.5k 0.9×	1.5k 0.7×	1.1k 0.7×	631 0.4×	116	10.6k
Caroline Seynaeve Netherlands	53	3.6k 1.0×	4.7k 1.7×	3.1k 1.4×	1.1k 0.7×	472 0.3×	189	9.4k
Christobel Saunders Australia	43	3.0k 0.8×	1.2k 0.4×	1.6k 0.7×	692 0.4×	1.1k 0.7×	318	7.1k
Vivianne C. G. Tjan‐Heijnen Netherlands	51	5.4k 1.5×	1.1k 0.4×	3.5k 1.6×	1.7k 1.0×	1.0k 0.7×	289	10.7k
N. Lynn Henry United States	39	4.6k 1.3×	1.5k 0.5×	2.9k 1.3×	822 0.5×	706 0.5×	208	8.1k
R.D. Rubens United Kingdom	46	3.7k 1.0×	1.2k 0.4×	2.1k 1.0×	818 0.5×	1.2k 0.8×	172	8.1k
Lucia Del Mastro Italy	48	5.3k 1.5×	1.6k 0.6×	2.5k 1.1×	555 0.3×	463 0.3×	332	8.7k
Nicole Rotmensz Italy	66	5.6k 1.5×	2.0k 0.7×	7.0k 3.2×	3.5k 2.1×	919 0.6×	223	12.0k
Claudine Isaacs United States	63	4.8k 1.3×	7.9k 2.9×	3.7k 1.7×	2.0k 1.2×	754 0.5×	279	13.8k

Countries citing papers authored by Ellen Warner

Since Specialization

Citations

This map shows the geographic impact of Ellen Warner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Warner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Warner more than expected).

Fields of papers citing papers by Ellen Warner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Warner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Warner. The network helps show where Ellen Warner may publish in the future.

Co-authorship network of co-authors of Ellen Warner

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Warner. A scholar is included among the top collaborators of Ellen Warner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Warner. Ellen Warner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moore-Palhares, Daniel, Lakshmanan Sannachi, Adrian Wai Chan, et al.. (2025). Validation of a Quantitative Ultrasound Texture Analysis Model for Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: A Prospective Serial Imaging Study. Cancers. 17(15). 2594–2594.

Sella, Tal, Shoshana M. Rosenberg, Gregory J. Kirkner, et al.. (2024). Breastfeeding experiences among young breast cancer survivors: A survey study. Cancer. 131(1). e35585–e35585. 3 indexed citations

Sella, Tal, Shoshana M. Rosenberg, Gregory J. Kirkner, et al.. (2023). Conception and pregnancy among women with a live birth after breast cancer treatment: A survey study of young breast cancer survivors. Cancer. 130(4). 517–529. 2 indexed citations

Sella, Tal, Shoshana M. Rosenberg, Shari Gelber, et al.. (2023). Abstract P5-08-06: Breastfeeding in Survivors of Early Breast Cancer. Cancer Research. 83(5_Supplement). P5–8. 2 indexed citations

Metcalfe, Kelly, May Lynn Quan, Steven A. Narod, et al.. (2023). Abstract P5-03-07: Prevalence of Pathogenic Variants in Cancer Predisposition Genes in Women with Young Onset Breast Cancer. Cancer Research. 83(5_Supplement). P5–3. 1 indexed citations

Sella, Tal, Geoffrey Fell, Peter G. Miller, et al.. (2022). Patient perspectives on testing for clonal hematopoiesis of indeterminate potential. Blood Advances. 6(24). 6151–6161. 8 indexed citations

Poorvu, Philip D., Jiani Hu, Yue Zheng, et al.. (2021). Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer. npj Breast Cancer. 7(1). 99–99. 19 indexed citations

Lefrère, Hanne, Giuseppe Floris, Marjanka K. Schmidt, et al.. (2021). Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome. European Journal of Cancer. 155. 13–24. 8 indexed citations

Carroll, June, Joanne Permaul, Kara Semotiuk, et al.. (2020). Hereditary colorectal cancer screening: A 10-year longitudinal cohort study following an educational intervention. Preventive Medicine Reports. 20. 101189–101189. 5 indexed citations

10.

Dasgupta, Archya, Arjun Sahgal, Ellen Warner, & Gregory J. Czarnota. (2020). Safety of palbociclib concurrent with palliative pelvic radiotherapy: discussion of a case of increased toxicity and brief review of literature. Journal of Medical Radiation Sciences. 68(1). 96–102. 12 indexed citations

11.

Chertok, Ilana R. Azulay, et al.. (2020). Infant feeding among women with a history of breast cancer. Journal of Cancer Survivorship. 14(3). 356–362. 9 indexed citations

12.

Chiarelli, Anna M., Kristina M. Blackmore, Derek Muradali, et al.. (2019). Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program. JNCI Journal of the National Cancer Institute. 112(2). 136–144. 56 indexed citations

13.

Poorvu, Philip D., Shari Gelber, Shoshana M. Rosenberg, et al.. (2019). Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer. Journal of Clinical Oncology. 38(7). 725–733. 48 indexed citations

14.

Eisen, Andrea, Kristina M. Blackmore, Wendy S. Meschino, et al.. (2018). Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program. Molecular Genetics & Genomic Medicine. 6(2). 213–223. 7 indexed citations

15.

Graham, Tracy, et al.. (2013). Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling. Annals of Oncology. 24. viii69–viii74. 83 indexed citations

16.

Metcalfe, Kelly, Henry T. Lynch, P Ghadirian, et al.. (2005). The Risk of Ovarian Cancer After Breast Cancer in BRCA1 and BRCA2 Carriers. Obstetrical & Gynecological Survey. 60(4). 235–236. 9 indexed citations

17.

Warner, Ellen, June Carroll, Ruth Heisey, et al.. (2003). Educating women about breast cancer. An intervention for women with a family history of breast cancer.. PubMed. 49. 56–63. 14 indexed citations

18.

Moslehi, Roxana, William Chu, Beth Y. Karlan, et al.. (2000). BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer. The American Journal of Human Genetics. 66(4). 1259–1272. 224 indexed citations

19.

Ondrusek, Nancy, Ellen Warner, & Vivek Goel. (1999). Development of a knowledge scale about breast cancer and heredity (BCHK). Breast Cancer Research and Treatment. 53(1). 69–75. 27 indexed citations

20.

Warner, Ellen, et al.. (1981). Benefits and risks of circumcision.. PubMed. 125(9). 967–76, 992. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact